Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD) [NA]

View source ↗

Summary

The ReDACKD trial is evaluating reducing dietary acid with food versus an oral alkali in people with chronic kidney disease, with the study currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dylan MacKay | Conditions: Chronic Kidney Diseases, Metabolic Acidosis | NA | Status: ACTIVE_NOT_RECRUITING